首页> 外文期刊>Clinical and Translational Oncology >Effect of surgical resection of metastatic disease on immune tolerance to cancer. How a systemic disease could be controlled by a local therapy
【24h】

Effect of surgical resection of metastatic disease on immune tolerance to cancer. How a systemic disease could be controlled by a local therapy

机译:手术切除转移性疾病对癌症免疫耐受的影响。局部疗法如何控制全身性疾病

获取原文
获取原文并翻译 | 示例
           

摘要

Surgery represents the only chance of cure for patients with colorectal liver metastases. The results of expanded indications for surgical treatment revealed that even advanced disease can be cured in a significant percentage of cases. What is the explanation for this systemic impact of a local treatment such as surgery? What is different in those patients who can be cured by resection? In this review we analyse the available evidence of the complex relationship between the growing tumour and the immune system. Special attention is directed to the role of T regulatory cells (Tregs) recruited by the tumour to construct a tolerogenic microenvironment in which to grow. Based on the published data we developed the hypothesis that surgery breaks the tumour immune tolerance status because it not only removes the tumour, but also the protective shield of T regulatory cells.
机译:外科手术是治愈结直肠肝转移患者的唯一机会。扩大手术治疗适应症的结果表明,即使是晚期疾病,也可以在相当多的病例中治愈。对于诸如手术之类的局部治疗的系统性影响有何解释?那些可以通过切除治愈的患者有什么不同?在这篇综述中,我们分析了正在生长的肿瘤与免疫系统之间复杂关系的可用证据。特别关注的是肿瘤募集的T调节细胞(Tregs)在构建可生长的致耐受性微环境中的作用。基于已公开的数据,我们提出了这样的假说,即外科手术不仅可以去除肿瘤,而且可以去除T调节细胞的保护层,从而破坏了肿瘤的免疫耐受状态。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号